Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis by Chun, Taehoon et al.
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2001/05/1213/08 $5.00
Volume 193, Number 10, May 21, 2001 1213–1220
http://www.jem.org/cgi/content/full/193/10/1213
 
Brief Deﬁnitive Report
 
1213
 
Induction of M3-restricted Cytotoxic T Lymphocyte 
Responses by 
 
N
 
-formylated Peptides Derived from 
 
Mycobacterium tuberculosis
 
By Taehoon Chun,
 
*
 
 Natalya V. Serbina,
 
‡
 
 Dawn Nolt,
 
§‡
 
 Bin Wang,
 
*
 
 
Nancy M. Chiu,
 
*
 
 JoAnne L. Flynn,
 
‡
 
 and Chyung-Ru Wang
 
*
 
From the 
 
*
 
Gwen Knapp Center for Lupus and Immunology Research, Committee on Immunology 
and Department of Pathology, University of Chicago, Chicago, Illinois 60637; and the 
 
‡
 
Department 
of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, 
Pennsylvania 15261; and the 
 
§
 
Department of Pediatrics, Division of Infectious Disease, Children’s 
Hospital, Pittsburgh, Pennsylvania 15261
 
Abstract
 
Major histocompatibility complex (MHC) class I–restricted CD8
 
1
 
 T cells play a critical role in
the protective immunity against 
 
Mycobacterium tuberculosis
 
 (Mtb). However, only a few Mtb
peptides recognized by MHC class Ia–restricted CD8
 
1
 
 T cells have been identified. Informa-
tion on epitopes recognized by class Ib–restricted T cells is even more limited. M3 is an MHC
class Ib molecule that preferentially presents 
 
N
 
-formylated peptides to CD8
 
1
 
 T cells. Because
bacteria initiate protein synthesis with 
 
N
 
-formyl methionine, the unique binding specificity of
M3 makes it especially suitable for presenting these particular bacterial epitopes. We have
scanned the full sequence of the Mtb genome for NH
 
2
 
-terminal peptides that share features
with other M3-binding peptides. Synthetic peptides corresponding to these sequences were
tested for their ability to bind to M3 in an immunofluorescence-based peptide-binding assay.
Four of the 
 
N
 
-formylated Mtb peptides were able to elicit cytotoxic T lymphocytes (CTLs)
from mice immunized with peptide-coated splenocytes. The Mtb peptide–specific, M3-restricted
CTLs lysed the Mtb-infected macrophages effectively, suggesting that these 
 
N
 
-formylated Mtb
peptides are presented as the naturally processed epitopes by Mtb-infected cells. Furthermore,
T cells from Mtb-infected lungs, spleen, and lymph nodes responded to 
 
N
 
-formylated Mtb
peptides in an M3-restricted manner. Taken together, our data suggest that M3-restricted T
cells may participate in the immune response to Mtb.
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Introduction
 
Tuberculosis is a leading cause of infectious mortality in the
 
world (1). The causative agent of tuberculosis, 
 
Mycobacter-
ium tuberculosis
 
 (Mtb), is an intracellular bacterial pathogen
that resides within phagosomes of infected macrophages.
Despite the noncytosolic location of Mtb, endogenous
 
Mtb-derived antigens can be presented to CD8
 
1
 
 T cells,
presumably through an alternative MHC class I antigen
processing pathway (2–4). Studies of experimental tubercu-
losis in mice indicate that CD8
 
1
 
 T cells contribute to im-
mune defense against Mtb by releasing cytokines such as
IFN-
 
g
 
 and TNF-
 
a
 
 and directly lysing infected cells (5–10).
Although the identification of Mtb antigens for T cell rec-
ognition is critical in the design of T cell–based vaccines,
relatively few T cell epitopes for Mtb-specific CD8
 
1
 
 T cells
have been identified. Among them are MHC class Ia–bind-
ing peptides derived from 38-kD lipoprotein (11), 19-kD
 
lipoprotein (12), and
 
 
 
early secretory antigenic target 6 (13)
and CD1-bound lipid antigens derived from the mycobac-
terial cell wall (14, 15). A recent study has shown that some
human Mtb-reactive CTLs are not restricted by MHC class
Ia nor by CD1 molecules, suggesting that other class Ib
molecules may be involved in presenting Mtb antigens (16).
H2-M3 is an MHC class Ib molecule that has a unique
specificity for 
 
N
 
-formylated hydrophobic peptides derived
from mitochondria and bacteria (17, 18). Given that class Ia
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molecules do not bind 
 
N
 
-formylated peptides appreciably
(19), M3 may have been selected in evolution for the spe-
cialized presentation of this conserved structure of bacterial
peptides. Three listerial antigens presented by M3 have
been defined: LemA, Fr 38, and AttM (20–22). Each anti-
gen is recognized by CTLs from infected animals. Adoptive
transfer of M3-restricted, LemA-specific CTLs can provide
protective immunity against listerial infection, indicating
that M3-restricted T cells may play a role in host defense
against intracellular bacterial infection (23).
Recently, we have shown that M3 surface expression is
undetectable in most cell types due to the lack of endoge-
nous antigens. The majority of M3 is retained in an imma-
ture peptide-receptive form and traffics rapidly to the cell
surface upon the addition of exogenous 
 
N
 
-formylated pep-
tide (24). This property allows us to search for novel patho-
gen-derived peptides that bind to M3 in normal APCs.
Identification of bacterial peptides that are able to prime an
M3-restricted CTL response will raise the prospect of using
these peptides in vaccine development.
In this study, we identified M3-binding peptides derived
from Mtb. We showed that CTLs with specificity for
 
N
 
-formylated Mtb peptides can be generated in mice.
These T cells are capable of lysing Mtb-infected macrophages.
In addition, M3-restricted 
 
N
 
-formylated peptide–specific T
cells are present in Mtb-infected mice, suggesting that the
M3-restricted T cells may contribute to the defense against
mycobacterial infection. These 
 
N
 
-formylated M3-binding
peptides identified from Mtb, a prominent human patho-
gen, may prove useful in the search for functional homo-
logues of M3 in humans.
 
Materials and Methods
 
Abs and Peptides.
 
Abs used in this study include: FITC-con-
jugated mAbs specific for hamster IgG; CD4 (RM4-5); TCR-
 
b
 
(H57-597); V
 
b
 
5 (MR9-4); V
 
b
 
6 (RR4-7); V
 
b
 
7 (TR310); V
 
b
 
8
(MR5-2); V
 
b
 
9 (MR10-2); V
 
b
 
12 (MR11-1); V
 
b
 
14 (14-2); and
V3
 
a
 
 (RR3-16); and PE-conjugated mAbs specific for CD8
 
a
 
(53-6.7); V
 
b
 
2 (B20.6); V
 
b
 
3 (KJ25); V
 
b
 
4 (KT4); V
 
b
 
10 (B21.5);
V
 
b
 
11 (RR3-15); V
 
b
 
13 (RR12-3); V
 
a
 
2 (B20.1); V
 
a
 
8 (B21.14);
and V
 
a
 
11 (RR8-1) (BD PharMingen). The hamster mAb130
was purified as described previously (24). Synthetic peptides were
purchased from Research Genetics. Peptide sequences are de-
scribed in Table I. All peptides were 
 
.
 
90% pure as determined
by mass spectrometry. Peptides were dissolved in DMSO at con-
centrations of 10 mM.
 
Bacteria.
 
Mtb (Erdman strain; Trudeau Institute, Saranac
Lake, NY) was passed through mice, grown in culture once, and
frozen in aliquots (25). Frozen aliquots were used to start cultures
at a concentration of 2.5 
 
3
 
 10
 
6
 
 cells/ml in liquid medium (7H9
Middlebrook; Difco Laboratories, Inc.), and bacteria were grown
in 5% CO
 
2
 
 at 37
 
8
 
C. 6–7-d-old cultures were used for infections.
Bacteria were washed and resuspended in DMEM (Life Technol-
ogies) before infection of cell cultures.
 
Cell Lines and Cell Cultures.
 
Fibroblast cell lines were main-
tained in RPMI 1640 (Mediatech) with 10% fetal bovine serum
(FBS), 2 mM 
 
L
 
-glutamine, 20 mM Hepes, 50 
 
m
 
M 2-ME, peni-
cillin, and streptomycin (RPMI 10), and the macrophage cell line
P388 was cultured in DMEM (Mediatech) containing 10% FBS.
 
For CTL assays, cells were harvested with 0.2% collagenase (type
IV) and EDTA-saline (140 mM NaCl, 5 mM KCl, 12.5 mM
Na
 
2
 
HPO
 
4
 
, 5.8 mM NaH
 
2
 
PO
 
4
 
, 0.2% glucose, and Na
 
2
 
EDTA,
pH 7.2). TR8.4a is a derivative of the B10.CAS2 fibroblast cell
line that has been transfected with genomic DNA encoding 
 
M3
 
wt
 
(26). P388-M3 is a macrophage cell line that has been transfected
with 
 
M3
 
 cDNA under the control of CMV promoter.
 
Computer-aided Search of M3-binding Peptide and Computer Mod-
eling.
 
The Mtb sequences in The Sanger Center database were
searched with the Findpattern program (Genetic Computer
Group) allowing no mismatches with the following sequence:
fM(Y,F,W,I,L)(Y,F,I,L,V)ZXX (Z, amino acid with nonpolar
side chain; X, any amino acid; reference 27). 41 peptides were
identified that bear this motif. We modeled 20 such peptides into
the binding groove of the M3/MTF crystal structure with pro-
gram O on a Silicon Graphics machine (28, 29). The backbone
conformation of the peptide was left unchanged, and rotameric
states of the new side chains were assigned to optimize van der
Waals interactions and avoid steric hindrance.
 
Induction of M3 on the Cell Surface by Mtb Peptides.
 
Spleno-
cyte suspensions were prepared from C57BL/6 (B6) mouse
spleens by mechanical disruption in RPMI 10. RBCs were re-
moved by hypotonic lysis. One million cells were incubated in
RPMI 10 with or without peptides overnight at 37
 
8
 
C. Cells were
harvested and washed three times with PBS before cell surface
staining experiments. M3 staining was detected by adding 100 
 
m
 
l
of hybridoma supernatants (mAb130) followed by mouse anti–
hamster IgG FITC. Staining with each reagent was performed for
30 min on ice in HBSS (Life Technologies) containing 2% FBS
and 0.1% sodium azide (Sigma Aldrich), followed by washing
with the same buffer. The stained cells were analyzed by flow
cytometry using a FACSCaliber™ (Becton Dickinson) with
CELLQuest™ software.
 
Generation and Maintenance of Mtb-specific CTL Lines.
 
5 
 
3
 
 10
 
6
 
splenocytes from B6 mice were cultured in 5 ml of RPMI 10 in
the presence of 10 
 
m
 
M Mtb peptide at 37
 
8
 
C. After overnight in-
cubation, cells were harvested, washed three times with PBS, and
 
Table I.
 
Synthetic Peptides Used in This Study
 
Peptide Sequence Gene designation and annotation
TB1 fMIVVLV Rv1021 (conserved hypothetical protein)
TB2 fMLVLLV Rv0476 (hydrophobic protein;
contains 
 
b
 
-ketoacyl synthase active site)
TB3 fMWYYLF Rv2182C (conserved hypothetical protein;
contains ATP/GTP binding site)
TB4 fMFLIDV Rv0277C (conserved hypothetical protein)
TB5 fMLFAAL Rv0072
(ABC-transporter transmembrane subunit)
TB6 fMFFLDA Rv0749(conserved hypothetical protein)
TB7 fMILLV Rv1686C
(probable transmembrane protein)
Fr38 fMIVIL Listerial peptide
LemA fMIGWII Listerial peptide
ND1 fMFFINIL Mitochondrial peptide
COI fMFINRW Mitochondrial peptide
 
The sequence and annotation information of Mtb was obtained from The
Sanger Center (GenBank/EMBL/DDBJ accession no. AL123456). 
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inactivated by gamma irradiation (1,500 rads). B6 mice were
primed with peptide-coated splenocytes through intraperitoneal
injection and footpad injection. After 1 wk, the mice were killed,
and their spleen cells were incubated with 10 
 
m
 
M peptides in
RPMI 10 at the concentration of 10
 
7
 
 cells per milliliter. Cultures
were restimulated weekly with peptide-pulsed syngenic spleno-
cytes (2–5 
 
3
 
 10
 
6
 
 cells per milliliter) and maintained in supple-
mented Mishell Dutton medium with IL-2 supplement (20 U/ml).
IL-2 for restimulations was partially purified from the supernatant
of EL4.IL2 cells (American Type Culture Collection), assayed,
and used as described in reference 30.
 
Culture and Infection of Macrophages.
 
Macrophages were
grown from bone marrow precursors of B6 mice. In brief, cells
were eluted from the femur and tibia bones of mice in DMEM
10. Cells were washed twice in DMEM, and 1–3 
 
3
 
 10
 
6
 
 cells
were plated in LabTek PS petri dishes (Fisher Scientific) in 25 ml
DMEM 10, 1 mM sodium pyruvate (Sigma Aldrich), 2 mM
 
L
 
-glutamine (Life Technologies, Inc.), and 33% supernatant from
L cell fibroblasts cultured for 5–7 d. All reagents were LPS-free,
and no antibiotics were used. Medium was changed once after
2–3 d of culture. On day 5, medium was replaced with DMEM
10, 1 mM sodium pyruvate, and 2 mM 
 
L
 
-glutamine. Cells were
then infected with Mtb at a multiplicity of infection of 2–5. The
percentage of infection was estimated in each experiment by
staining aliquots of cells by the Kinyoun method for acid-fast bac-
teria (Difco Laboratories, Inc.). After 15–48 h of infection (de-
pending on the assay), adherent cells were prepared for use as tar-
gets in CTL assays.
 
CTL Assays.
 
One million target cells were incubated in
RPMI 10 with or without 10 
 
m
 
M peptide overnight. After incu-
bation with peptide, cells were washed free of excess peptide and
labeled with 100 
 
m
 
Ci [
 
51
 
Cr]–sodium chromate for 1 h at 37
 
8
 
C.
For infected macrophages, cells were washed twice with ice-cold
PBS, incubated for 20 min on ice, and harvested by forceful pi-
petting before labeling in Teflon jars (Savillex). Target cells (10
 
4
 
cells) were added to round-bottomed microtiter wells containing
effector cells. After 4 h, 100 
 
m
 
l of supernatant from each well was
collected and assayed for 
 
51
 
Cr release. The percentage of specific
lysis 
 
5
 
 (experimental release 
 
2
 
 spontaneous release)/(maximal
release
 
 2
 
 spontaneous release) 
 
3 
 
100.
 
IFN-
 
g
 
 Assay.
 
CTLs (10
 
5
 
 cells/well) were stimulated with
gamma-irradiated B6 splenocytes (10
 
5
 
 cells/well) in a final vol-
ume of 200 
 
m
 
l of RPMI 10 in the presence or absence of 10 mM
Mtb peptide. After 48 h, the culture supernatants were harvested,
and the levels of IFN-g were quantitated by sandwich ELISA us-
ing commercial mAb pairs (BD PharMingen) according to the
manufacturer’s instructions.
In Vitro IFN-g Production by Lymphocytes from Mtb-infected
Mice. B6 and KbDb knockout (KO) mice (in B6 background;
reference 31) were infected intravenously via tail vein with 105
live bacilli. At 10 and 21 d after infection, lungs, pulmonary
lymph nodes, and spleens were harvested. Single-cell suspensions
were obtained by crushing the organs in cell strainders (Becton
Dickinson). RBCs were removed by hypotonic lysis, and the
cells were washed extensively. Cells were resuspended in T cell
medium (DMEM supplemented with 10% FBS, 1 mM sodium
pyruvate, 2 mM L-glutamine, 25 mM Hepes, and 1% nonessen-
tial amino acids) and plated onto culture dishes for 1 h at 378C to
deplete macrophages. Lung and lymph node cells (8 3 104 and
2 3 105 cells per well, respectively) were stimulated with P388–M3
(1:1 ratio), pulsed with either a mixture of Mtb peptides (TB1-7,
2 mM each) or LemA in the presence or absence of an anti-M3
Ab (mAb130). Each condition was plated in triplicate wells in 96-
well plates; each well contained a total volume of 200 ml. Spleen
cells (2 3 105 cells/well) were stimulated as above, except P388–
M3 pulsed with 10 mM of each TB peptide were also included as
stimulators. After a 4-d incubation at 378C, supernatants from
each well were filtered with 0.45-mm filter to remove Mtb before
testing for IFN-g.
Results
Identification of M3-binding Peptides from the Predicted Pro-
tein Sequences of Mtb. We searched the predicted protein
coding sequences from Mtb for NH2-terminal peptides that
share features with other M3-binding peptides. These pep-
tides were then modeled into the M3 structure with Pro-
gram O on a Silicon Graphics machine. Seven of these
N-formylated peptides that fit well to the M3-binding
groove were synthesized and tested for M3 binding by
analysis of their capacity to induce M3 surface expression
(Table I). P388-M3 cells, an M3-transfected macrophage
cell line, were incubated overnight with various concentra-
tions of each Mtb peptide. Surface expression of M3 was
determined by immunofluorescence assay with an anti-M3
mAb (mAb130). Fig. 1 shows that six of these Mtb peptides
can significantly induce M3 surface expression. TB1 and
TB7 have the highest affinity for M3, followed by TB2 and
TB4, and then by TB3 and TB6. TB5 enhances M3 ex-
pression only slightly. The affinity of TB1 and TB7 to M3
is comparable to two other M3-binding peptides derived
from Listeria, namely LemA and Fr38.
Figure 1. N-formylated Mtb peptides increase surface
expression of M3. P388-M3 transfectants were incubated
overnight with varying concentrations of N-formylated
peptides and stained for M3 expression. The range of con-
centrations and the corresponding hatchmarks are shown.
The bars represent mean fluorescence intensity after stain-
ing with mAb130 as described. The results are representa-
tive of two experiments.1216 M3-restricted CTL Responses against Mycobacterium tuberculosis
Generation of M3-restricted Mtb-specific CTLs. Four Mtb
peptides, TB2, TB4, TB6, and TB7, were chosen to repre-
sent groups that increase M3 surface levels to different ex-
tents. To access the immunogenecity, we analyzed their
ability to elicit peptide-specific CTLs after in vivo priming.
Eight long-term CTL lines were established from eight B6
mice (H-2b,  M3wt) immunized with TB peptide-coated
splenocytes and maintained by in vitro restimulation with
irradiated splenocytes pulsed with the immunizing peptide.
Cytotoxicity assays were performed to determine the anti-
gen specificity of these CTLs. To address the question of
whether these CTLs are restricted by M3, we used a
B10.CAS2 fibroblast cell line that expresses an M3 allele
(M3cas) that does not present N-formylated peptide effi-
ciently and an M3wt-transfected B10.CAS2 (TR8.4a) as tar-
gets. All eight CTL lines lysed TR8.4a cells sensitized with
the stimulating peptide but failed to recognize B10.CAS2
fibroblasts sensitized with the same peptide (Fig. 2 A). Lysis
of TR8.4a was peptide dependent, as TR8.4a cells alone
were not lysed. To determine whether these TB peptides
are presented exclusively by M3, we tested the ability of
anti-M3 Ab to block the killing by CTLs of the peptide-
sensitized P388 (H-2d, M3wt) cells. As shown in Fig. 2 B,
mAb130 completely blocked the killing of all Mtb-specific
CTL lines tested. Together, these results suggest that M3
presents N-formylated Mtb peptides to the CTLs.
A previous study showed that the majority of M3-
restricted Listeria-specific CTL clones responded to multi-
ple N-formylated peptides, indicating that M3-restricted T
cells might be highly cross-reactive (32). To gain insight
into the peptide specificity of these Mtb-specific CTLs, we
examined the responses of four representative CTL lines to
a panel of N-formylated peptides, including TB2, TB4,
TB6, TB7, two mitochondrial peptides (ND1 and COI),
and listerial LemA peptide (Fig. 2 C). All four CTL lines
preferentially lysed the target cells pulsed with N-formyl-
ated peptide used for in vitro stimulation, although low
levels of cross-reactivity with one or two peptides from this
Figure 2. Mtb peptide-specific CTLs lyse targets in an M3-restricted,
peptide-dependent manner. (A) The M3wt-transfected TR8.4a (H2-M3wt)
and untransfected B10.CAS2 (H2-M3cas) fibroblast cell lines were incu-
bated overnight with or without 10 mM of Mtb peptides and used as tar-
gets in a 51Cr-release assay. (B) The macrophage cell line P388 (H-2d, H2-
M3wt) was incubated overnight with or without 10 mM of Mtb peptides
and used as target. The Mtb-specific CTL lines were incubated with tar-
get cells in the presence of either 100 ml of mAb130 hybridoma superna-
tant or 100 ml of RPMI 10 in a 4-h 51Cr-release assay. The E/T ratios are
shown. (C) P388 was incubated overnight with 10 mM of various
N-formylated peptides and used as target. The E/T ratio for all CTLs
is 3:1. Results were comparable in two experiments.1217 Chun et al. Brief Definitive Report
panel could be detected. Thus, the recognition of these
Mtb-specific CTLs are peptide specific.
Mtb Peptide–specific CTLs Can Effectively Kill Mtb-infected
Macrophages. To assess whether Mtb peptide–induced
CTLs can recognize naturally processed mycobacterial anti-
gens, we performed CTL assays using Mtb-infected mac-
rophages as target cells. M3 surface expression was not de-
tectable on uninfected macrophages. Upon infection,
expression increased to low but detectable levels (data not
shown). The infected macrophages were specifically lysed
by all the Mtb peptide-specific CTL lines (Fig. 3) but were
insensitive to the lysis by a Listeria-specific M3-restricted
CTL clone, D7 (33). The lysis of infected macrophages by
M3-restricted Mtb peptide–specific CTLs indicates that
these N-formylated peptides are naturally processed and
presented by M3 in Mtb-infected macrophages. Macro-
phages infected for 12–18 h were already recognized by
M3-restricted CTL, although in some experiments lysis
was improved if the infection of macrophages was allowed
to progress for 48 h before use in the CTL assay.
Characterization of M3-restricted Mtb-specific CTLs. Sur-
face phenotypes and TCR usage of these Mtb-specific
CTLs were determined by flow cytometric analysis. The
results are summarized in Table II. All of the CTL lines ex-
press ab TCRs, and most of the lines use different combi-
nations of the Va and the Vb segments, suggesting that the
T cell repertoire for M3-restricted responses is not limited.
Four of the Mtb-specific CTL lines express the CD8 core-
ceptor, while the other four CTLs do not express CD4 or
CD8 coreceptors. As both CD81 and dominant negative
(DN) CTLs can lyse Fas-negative target cells such as pep-
tide-pulsed fibroblasts, it is likely that both types of M3-
restricted CTLs can lyse the targets via the granule exocy-
tosis pathway. However, in the case of the CD1-restricted,
Mtb-specific CTLs, the CD81 CD1-restricted CTLs lysed
infected cells by a granule-dependent mechanism, whereas
the DN CD1-restricted CTLs lysed targets through Fas–
FasL interaction (34).
Production of IFN-g by T cells is one of the protective
mechanisms against bacterial pathogens and is particularly
crucial in controlling tuberculosis (35, 36). To test the abil-
ity of Mtb-specific CTLs to secrete IFN-g, we measured
IFN-g secreted in response to peptide-pulsed B6 spleno-
cytes. As shown in Table II, all of the CTLs produced sig-
nificant amounts of IFN-g in response to stimulation with
Mtb peptide–pulsed splenocytes. Thus, these M3-restricted,
Mtb-specific CTLs could directly lyse the infected cells and
release IFN-g to modulate the cell-mediated immune re-
sponse against Mtb.
M3-restricted T Cells Participate in Immune Response to Mtb
In Vivo. Although the M3-restricted CTL lines were ca-
pable of recognizing antigen presented by infected mac-
Figure 3. Mtb peptide–specific, M3-restricted CTLs recognize Mtb-infected
macrophages and are primed in infected mice. (A) Bone marrow–derived mac-
rophages were either maintained in medium alone or acutely infected with Mtb.
After 48 h, adherent cells were harvested, labeled with 51Cr, and used as targets
in a CTL assay. Black bars represent the specific lysis of infected macrophages by
various Mtb peptide–specific CTLs, and the lysis of uninfected macrophages
(white bars) was included for comparison. The E/T ratio was 30:1 for CTL4B
and 10:1 for the rest of the CTL lines. Results shown are the means from triplicate wells and the standard errors were ,5%. Results were comparable in
three experiments. (B) IFN-g production by lymphocytes from Mtb-infected mice in response to Mtb peptide stimulation. Lymphocytes from lung and
lymph nodes (LN) and spleen of KbDb KO or B6 mice were harvested at 21 d after infection and stimulated with a mixture of TB peptides (TB1–TB7, 2
mM each). After 4 d, the amounts of IFN-g in the culture supernatants were measured by ELISA. Results shown are the means from triplicate wells, and
the standard errors are shown. (C) Reactivity of splenocytes from Mtb-infected mice to various TB peptides. Splenocytes from mice at 21 d after infec-
tion were stimulated with each TB peptide (10 mM) in the presence or absence of an anti-M3 Ab (mAb130). After 4 d, the levels of IFN-g in the culture
supernatants were quantitated by ELISA. Splenocytes from uninfected mice did not secrete detectable amounts of IFN-g in response to TB peptide stim-
ulation. For B and C, three KbDb KO and two B6 mice were used for each experiment, and the results were comparable in two experiments. Cells from
mice infected for 10 d gave similar results but with lower IFN-g production.1218 M3-restricted CTL Responses against Mycobacterium tuberculosis
rophages, it remained to be determined whether T cells spe-
cific for these N-formylated peptides were elicited in
response to Mtb infection in mice. Lymphocytes were iso-
lated from Mtb-infected mice at 10 and 21 d after infection
and examined for IFN-g production by restimulating in
vitro with either a mixture of TB peptides (TB1-7) or indi-
vidual TB peptide. Both KbDb KO and B6 mice were ex-
amined to determine whether M3-restricted responses are
augmented in the absence of class Ia molecules. At 21 d after
infection, lymphocytes harvested from lungs, lymph nodes,
and spleens of infected KbDb KO and B6 mice secreted
IFN-g upon in vitro stimulation with TB1-7, but not with
LemA peptide (Fig. 3 B). The response was blocked by the
addition of anti-M3 Ab (mAb130), suggesting that TB pep-
tide–specific, M3-restricted T cells are present in Mtb-
infected mice. Similar results were obtained with lympho-
cytes isolated from infected mice at 10 d after infection, but
the magnitude of the response was lower (data not shown).
Three out of the seven TB peptides, TB2, TB4, and TB7,
readily induced IFN-g from the spleen cells of infected B6
and KbDb KO mice (Fig. 3 C), but not from uninfected
mice (data not shown). The response to TB1 was only de-
tected from infected KbDb KO mice. In addition, lympho-
cytes from infected K bDb KO mice secreted substantially
larger amounts of IFN-g in response to TB peptides, indi-
cating that M3-restricted T cells are enriched in KbDb KO
mice. Taken together, these results suggest that N-for-
mylated M3-binding peptides are effectively presented dur-
ing Mtb infection, and the resulting M3-restricted T cells
may contribute to the immunity against Mtb.
Discussion
The Mtb genome sequence was published recently (27).
This allowed us to search for N-formylated mycobacterial
peptides with sequence homology to other M3-binding
peptides. More than 40 candidate peptides were identified
from 3,924 predicted protein coding sequences of Mtb.
Our analysis of the four candidate peptides demonstrates
the feasibility of using this approach to identify functionally
relevant epitopes for M3-restricted T cells in Mtb infection.
The fact that all of the CTLs elicited by these four
N-formylated Mtb peptides can recognize and lyse Mtb-
infected macrophages suggests that the N-formylated pep-
tides might be prevalent antigens during bacterial infections.
In addition, three N-formylated peptides used in this study
can be effectively presented by M3 in Mtb-infected mice,
suggesting that N-formylated peptide–specific, M3-restricted
T cells may play a role in the immune response to Mtb.
The unique ligand specificity of M3 may contribute to
its efficacy in antigen presentation by allowing N-for-
mylated antigenic peptides access to a pool of empty M3 in
the endoplasmic reticulum without competition from many
self-peptides (24). During infection, presentation of
N-formylated bacterial peptides by M3 is rapid and undi-
luted, which might provide a potent activation signal to
M3-restricted T cells. Consistent with this notion, Kerksiek
et al. (37) have shown that M3-restricted responses appear
to be earlier and more prominent than class Ia–restricted re-
sponses in the primary infection of mice with Listeria mono-
cytogenes. In our studies, the response to the N-formylated
TB peptides was stronger at 21 d after infection compared
with 10 d after infection, suggesting that the kinetics of the
response may vary with different pathogens. N-formyl
modification is a feature common to bacterial proteins.
Thus, it is possible that M3 might be able to present anti-
gens derived from a variety of intracellular bacteria, and
M3-restricted responses might contribute to the defense
against infection by a wide range of intracellular pathogens.
Limited polymorphism of M3 suggests that M3 may
have evolved to present conserved and unique ligands to T
cells. Focusing the immune response on common micro-
bial entities that are rare or absent from host cells can
broaden the host specificity against infectious agents with-
out increasing the risk of autoimmunity. The CD1 mole-
cules exemplify this strategy by presenting bacterial lipids to
T cells (14, 15). N-formylated peptides are extremely rare
in mammalian cells but serve as a widely used signal se-
quence for protein secretion in bacteria. Therefore, it
would be advantageous for the host to preserve such anti-
gen presentation through evolution. Although Southern
blot analysis failed to detect M3 orthologs in humans (26),
it remains to be determined whether functional homo-
logues of M3 exist in humans. HLA-E and Qa-1 do not
share striking sequence similarity to each other, although
each appear to have evolved to bind leader peptides of class
Ia molecules in humans and mice, respectively (38, 39).
MHC-unrestricted, Mtb-specific CTLs have been iden-
tified in humans (16). However, the antigen(s) and the re-
striction element(s) for these CTLs have not been deter-
mined. Our results suggest that if a human homologue of
M3 exists, it would be possible to elicit CTL responses
from infected individuals by in vitro stimulation with Mtb-
Table II. Surface Phenotypes and IFN-g Secretion of Mtb-specific 
CTLs
CTL
Peptide
specificity
Surface
phenotype*
IFN-g
secretion‡
U/ml
2A TB2 DN, TCR-ab1 (Va31Vb8+) 26 6 5
2B TB2 DN, TCR-ab1 (Va111Vb61) 18 6 1
4A TB4 CD81, TCR-ab1 (Va21Vb141) 73 6 15
4B TB4 CD81, TCR-ab1 (Va:UNKVb81) 49 6 10
6A TB6 DN, TCR-ab1 (Va21Vb101) 34 6 8
6B TB6 CD81, TCR-ab1 (Va21Vb:UNK) 24 6 2
7A TB7 DN, TCR-ab1 (Va:UNKVb51) 116 6 6 
7B TB7 CD81, TCR-ab1 (Va31Vb51) 115 6 5
*CTL lines were stained with various Abs and analyzed by FACS®. 
DN, CD42CD82; UNK, unknown, i.e., no positive staining with the Abs
specific to the following V segments: Va2, 3, 8, and 11 and Vb2–14 and 17.
‡Antigen-dependent IFN-g production by Mtb-specific CTLs was assessed in
response to various Mtb peptide–pulsed splenocytes. CTLs cultured with sple-
nocytes alone did not secrete detectable amounts of IFN-g  (,1 U/ml).1219 Chun et al. Brief Definitive Report
derived N-formylated peptides. Currently, we are attempt-
ing to use the M3-binding peptides described in our study
as candidate peptides for developing human CTLs. If this
approach succeeds, N-formylated peptides presented by a
nonpolymorphic MHC molecule could potentially be used
as novel vaccines against Mtb infection in a broad range of
recipients.
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